Severe myoclonic epilepsy of infancy+1
Not recruitingLong-Term Safety Study of Fenfluramine Hydrochloride for Seizures in Patients with Dravet or Lennox-Gastaut Syndrome
Long-Term Safety Study of Fenfluramine Hydrochloride for Seizures in Patients with Dravet or Lennox-Gastaut Syndrome
- Disease:Severe myoclonic epilepsy of infancyLennox-Gastaut syndrome
- Substances:Fenfluramine Hydrochloride
Italy- Participants:0–17 years · 18–64 years
- Substances:Fenfluramine Hydrochloride
- Sponsor:Zogenix International Limited











